Literature DB >> 30051373

Relationship of Interferon-γ to Cognitive Function in Midlife Women with Schizophrenia.

Kathleen E Wilson1, Haley Demyanovich2, Leah H Rubin3, Heidi J Wehring2, Catherine Kilday2, Deanna L Kelly2.   

Abstract

Recent literature suggests that schizophrenia is linked to an abnormal response of the immune system. Interferon-γ is a cytokine that acts as a mediator between immune stimulation and the kynurenine pathway and may be related to cognitive abilities. The objectives of the present study are to determine if serum cytokines are correlated with cognitive function differently in patients with schizophrenia compared to controls. Fourteen midlife (30-70 year-old) females with DSM-IV diagnosis of schizophrenia or schizoaffective disorder and 13 midlife control females were analyzed. Cytokines were collected from serum blood draws and analyzed at the Cytokine Core Lab at the University of Maryland, Baltimore. The RBANS, HVLT-R, and UPSA were performed to measure cognition and social performance. The results demonstrate a non-significant difference between interferon-γ levels in women with schizophrenia compared to controls, but this cytokine appears to correlate to cognitive abilities differently in these groups. There were several significant negative correlations between interferon-γ and cognition in midlife patients with schizophrenia, but only one in the midlife control group. The negative correlations between interferon-γ and cognition in patients with schizophrenia suggest the hypothesis that inflammation and the kynurenine pathway have important roles in this disorder.

Entities:  

Keywords:  Cognition; Cytokines; Inflammation; Schizophrenia; Women

Mesh:

Substances:

Year:  2018        PMID: 30051373     DOI: 10.1007/s11126-018-9591-6

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  34 in total

1.  UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults.

Authors:  T L Patterson; S Goldman; C L McKibbin; T Hughs; D V Jeste
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

2.  Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment.

Authors:  V Arolt; M Rothermundt; K P Wandinger; H Kirchner
Journal:  Mol Psychiatry       Date:  2000-03       Impact factor: 15.992

Review 3.  Assessing and treating cognitive impairment in schizophrenia: current and future.

Authors:  Chun-Yuan Lin; Guochuan E Tsai; Hsien-Yuan Lane
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

4.  Test-retest stability of the Repeatable Battery for the Assessment of Neuropsychological Status in schizophrenia.

Authors:  Christopher M Wilk; James M Gold; John J Bartko; Faith Dickerson; Wayne S Fenton; Michael Knable; Christopher Randolph; Robert W Buchanan
Journal:  Am J Psychiatry       Date:  2002-05       Impact factor: 18.112

5.  Increased cortical kynurenate content in schizophrenia.

Authors:  R Schwarcz; A Rassoulpour; H Q Wu; D Medoff; C A Tamminga; R C Roberts
Journal:  Biol Psychiatry       Date:  2001-10-01       Impact factor: 13.382

Review 6.  Sex differences in autoimmune disease from a pathological perspective.

Authors:  DeLisa Fairweather; Sylvia Frisancho-Kiss; Noel R Rose
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

7.  Sex differences in cognitive trajectories in clinically normal older adults.

Authors:  Anna C McCarrey; Yang An; Melissa H Kitner-Triolo; Luigi Ferrucci; Susan M Resnick
Journal:  Psychol Aging       Date:  2016-01-21

8.  Why sex differences in schizophrenia?

Authors:  Rena Li; Xin Ma; Gang Wang; Jian Yang; Chuanyue Wang
Journal:  J Transl Neurosci (Beijing)       Date:  2016-09

Review 9.  The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders.

Authors:  Trevor W Stone; L Gail Darlington
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

10.  Epidemiological and Experimental Evidence for Sex-Dependent Differences in the Outcome of Leishmania infantum Infection.

Authors:  Nilda E Rodríguez; Iraci D Lima; Upasna Gaur Dixit; Elizabeth A Turcotte; Ryan D Lockard; Hemali Batra-Sharma; Eliana L Nascimento; Selma M B Jeronimo; Mary E Wilson
Journal:  Am J Trop Med Hyg       Date:  2018-01       Impact factor: 2.345

View more
  5 in total

1.  The relationship between immune and cognitive dysfunction in mood and psychotic disorder: a systematic review and a meta-analysis.

Authors:  M Morrens; C Overloop; V Coppens; E Loots; M Van Den Noortgate; S Vandenameele; M Leboyer; L De Picker
Journal:  Mol Psychiatry       Date:  2022-04-28       Impact factor: 15.992

2.  IL-4Rα deletion disrupts psychomotor performance and reference memory in mice while sparing behavioural phenotype associated with spatial learning.

Authors:  T M Brombacher; D C Ajonijebu; M Scibiorek; I Berkiks; B O Moses; T Mpotje; F Brombacher
Journal:  Brain Behav Immun       Date:  2020-12-08       Impact factor: 7.217

Review 3.  Genetic and molecular biology of autism spectrum disorder among Middle East population: a review.

Authors:  Zahra Rahmani; Mohammad Reza Fayyazi Bordbar; Mohsen Dibaj; Maliheh Alimardani; Meysam Moghbeli
Journal:  Hum Genomics       Date:  2021-03-12       Impact factor: 4.639

4.  Risk Prediction of Coronary Artery Stenosis in Patients with Coronary Heart Disease Based on Logistic Regression and Artificial Neural Network.

Authors:  Xiaobing Cheng; Weixing Han; Youfeng Liang; Xianhe Lin; Juanjuan Luo; Wansheng Zhong; Dong Chen
Journal:  Comput Math Methods Med       Date:  2022-03-19       Impact factor: 2.238

Review 5.  L1 Retrotransposons: A Potential Endogenous Regulator for Schizophrenia.

Authors:  Muhammad Jahangir; Li Li; Jian-Song Zhou; Bing Lang; Xiao-Ping Wang
Journal:  Front Genet       Date:  2022-06-27       Impact factor: 4.772

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.